Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Proc Natl Acad Sci U S A
1994 Oct 25;9122:10320-4.
Show Gene links
Show Anatomy links
Characterization of the platelet-activating factor acetylhydrolase from human plasma by heterologous expression in Xenopus laevis oocytes.
Yamada Y, Stafforini DM, Imaizumi T, Zimmerman GA, McIntyre TM, Prescott SM.
???displayArticle.abstract???
Platelet-activating factor (PAF) has been implicated as a mediator of inflammation and atherosclerosis. A specific degradative enzyme found in plasma, PAF acetylhydrolase, plays important roles in various pathophysiological events induced by PAF. Human macrophages and Hep G2 cells secrete PAF acetylhydrolase with characteristics identical to the plasma activity. Other investigators reported that apolipoprotein B may possess phospholipase A2 activity, which suggested that apolipoprotein B might be a zymogen for PAF acetylhydrolase. However, while macrophages express PAF acetylhydrolase activity, we did not detect cDNAs for apolipoprotein B in a cDNA library from these cells, indicating that macrophages do not express this protein. In contrast, Hep G2 cells had high levels of cDNA for apolipoprotein B, as expected. We next injected Xenopus laevis oocytes with poly(A)+ RNA extracted from cultured human macrophages and Hep G2 cells. Twenty-five to 50% of Xenopus oocytes injected with poly(A)+ RNA from macrophages or Hep G2 cells secreted a PAF acetylhydrolase activity (1.0-7.8 nmol/ml per h) that also utilized a synthetic oxidized phospholipid as substrate. The activity secreted by poly(A)+ RNA-injected oocytes associated with lipoproteins and transferred between the particles in a pH-dependent manner, much like the plasma activity. These experiments establish that the properties of the enzyme released from poly(A)+ RNA-injected oocytes are identical to those of the plasma form of PAF acetylhydrolase and that the activity detected is not the expression of a domain in apolipoprotein B.
Chen,
The complete cDNA and amino acid sequence of human apolipoprotein B-100.
1986, Pubmed
Chen,
The complete cDNA and amino acid sequence of human apolipoprotein B-100.
1986,
Pubmed Cladaras,
The complete sequence and structural analysis of human apolipoprotein B-100: relationship between apoB-100 and apoB-48 forms.
1986,
Pubmed Dumont,
Oogenesis in Xenopus laevis (Daudin). I. Stages of oocyte development in laboratory maintained animals.
1972,
Pubmed
,
Xenbase Elstad,
Platelet-activating factor acetylhydrolase increases during macrophage differentiation. A novel mechanism that regulates accumulation of platelet-activating factor.
1989,
Pubmed Elstad,
Synthesis and release of platelet-activating factor by stimulated human mononuclear phagocytes.
1988,
Pubmed Grunfeld,
Identification of the intact insulin receptor using a sequence-specific antibody directed against the C-terminus of the beta-subunit.
1987,
Pubmed Hanahan,
Platelet activating factor: a biologically active phosphoglyceride.
1986,
Pubmed Hirata,
Cloning and expression of cDNA for a human thromboxane A2 receptor.
1991,
Pubmed
,
Xenbase Honda,
Cloning by functional expression of platelet-activating factor receptor from guinea-pig lung.
1991,
Pubmed
,
Xenbase Houamed,
Cloning, expression, and gene structure of a G protein-coupled glutamate receptor from rat brain.
1991,
Pubmed
,
Xenbase Julius,
Molecular characterization of a functional cDNA encoding the serotonin 1c receptor.
1988,
Pubmed
,
Xenbase Lester,
Heterologous expression of excitability proteins: route to more specific drugs?
1988,
Pubmed Liu,
New procedures for preparation and isolation of conjugates of proteins and a synthetic copolymer of D-amino acids and immunochemical characterization of such conjugates.
1979,
Pubmed Masu,
cDNA cloning of bovine substance-K receptor through oocyte expression system.
,
Pubmed
,
Xenbase Narahara,
Effects of endotoxins and cytokines on the secretion of platelet-activating factor-acetylhydrolase by human decidual macrophages.
1993,
Pubmed Parthasarathy,
Essential role of phospholipase A2 activity in endothelial cell-induced modification of low density lipoprotein.
1985,
Pubmed Parthasarathy,
Phospholipase A2 activity of low density lipoprotein: evidence for an intrinsic phospholipase A2 activity of apoprotein B-100.
1990,
Pubmed Patel,
Novel leukocyte agonists are released by endothelial cells exposed to peroxide.
1992,
Pubmed Prescott,
Platelet-activating factor.
1990,
Pubmed Satoh,
Platelet-activating factor (PAF) stimulates the production of PAF acetylhydrolase by the human hepatoma cell line, HepG2.
1991,
Pubmed Smiley,
Oxidatively fragmented phosphatidylcholines activate human neutrophils through the receptor for platelet-activating factor.
1991,
Pubmed Stafforini,
Human macrophages secret platelet-activating factor acetylhydrolase.
1990,
Pubmed Stafforini,
Platelet-activating factor acetylhydrolase from human plasma.
1990,
Pubmed Stafforini,
Platelet-activating factor acetylhydrolase in human erythrocytes.
1991,
Pubmed Stafforini,
The platelet-activating factor acetylhydrolase from human plasma prevents oxidative modification of low-density lipoprotein.
1992,
Pubmed Stafforini,
Human plasma platelet-activating factor acetylhydrolase. Association with lipoprotein particles and role in the degradation of platelet-activating factor.
1987,
Pubmed Stafforini,
Human plasma platelet-activating factor acetylhydrolase. Purification and properties.
1987,
Pubmed Stafforini,
Lipoproteins alter the catalytic behavior of the platelet-activating factor acetylhydrolase in human plasma.
1989,
Pubmed Steinberg,
Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity.
1989,
Pubmed Stremler,
Human plasma platelet-activating factor acetylhydrolase. Oxidatively fragmented phospholipids as substrates.
1991,
Pubmed Stremler,
An oxidized derivative of phosphatidylcholine is a substrate for the platelet-activating factor acetylhydrolase from human plasma.
1989,
Pubmed Tarbet,
Liver cells secrete the plasma form of platelet-activating factor acetylhydrolase.
1991,
Pubmed Vaitukaitis,
Production of antisera with small doses of immunogen: multiple intradermal injections.
1981,
Pubmed Vu,
Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation.
1991,
Pubmed
,
Xenbase Wallace,
Protein incorporation by isolated amphibian oocytes. 3. Optimum incubation conditions.
1973,
Pubmed
,
Xenbase
